Smarter Healthcare Starts with MSK Cost Control
MSK conditions drive some of the highest healthcare costs—often due to unnecessary surgeries.
Regenexx helps self-funded employers cut spend, speed up recovery, and offer a proven alternative that strengthens your benefits strategy.
MSK Spend Deserves a Closer Look
Musculoskeletal (MSK) conditions – including back, joint, and soft tissue disorders – are consistently one of the top three healthcare cost drivers for employer-sponsored healthcare plans.
For many large employer groups, MSK spend ranks first or second among all Major Diagnostic Categories (MDCs), often accounting for 15-20% of other total medical spend.
What’s Driving The Cost?
Systemic Overuse
Surgery, imaging, and prescription meds are frequently used — even when avoidable — driving up claims.
Delayed Access to Care
Employees often face delays in getting conservative care, leading to worsening conditions and costlier interventions.
Lost Time, Lost Productivity
Chronic MSK pain contributes to long-term disability, absenteeism, and lost workforce performance.
Proven Value for Employers, Groups, and Members
Solutions that reduce unnecessary procedures, improve care pathways, and engage employees early can create substantial win-win value for groups and members. Listen to what some of our members have to say about the Regenexx Corporate Program and the Regenexx approach to MSK care.
Health Plan Value
- Save up to 70% compared to surgical options
- Reduce absenteeism
- Reduce opioid medications
- Activity as tolerated recovery
- An innovative option in MSK care
- Increased affordability
- Low-risk treatments – injection based vs. surgery
- Access to leading specialist physicians
- No cost to add or implement
- Can be implemented at any time – no need to wait for plan renewal
- Turnkey member communication drive awareness and engagement
- Utilization program based on member education
Advanced Biotechnology, Ready for Your Health Plan
Adding new technologies to a self-funded health plan can be risky-unless they’re built to meet rigorous medical and insurance standards.
That’s what makes Regenexx different. Unlike most investigational treatments, the Regenexx approach meets the criteria insurers use to evaluate whether a treatment is ready for coverage.
What Makes Regenexx Eligible for Plan Integration?
Outcomes tracking
Leadership in research
Regulatory requirements
Improved outcomes
Trusted by Leading U.S. Employers to Reduce Healthcare Spend
